Brick & Kyle, Associates Bristol Myers Squibb CO Transaction History

Brick & Kyle, Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Jun 14, 2019	SELL	$45.12 - $53.8 $180,976 - $215,791	-4,011 Reduced 10.57%	33,946 $0
Q4 2018 Jun 13, 2019	SELL	$48.76 - $63.23 $117,609 - $152,510	-2,412 Reduced 5.97%	37,957 $1.97 Million
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $641,326 - $799,342	-12,692 Reduced 23.92%	40,369 $2.23 Million
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $35,472 - $40,836	-592 Reduced 1.1%	53,061 $3.36 Million
Q4 2017 Jan 24, 2018	SELL	$59.94 - $65.35 $16,063 - $17,513	-268 Reduced 0.5%	53,653 $3.29 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $2.98 Million - $3.44 Million	53,921	53,921 $3.44 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Brick & Kyle, Associates, based on Form 13F filings with the SEC.

Stay updated on Brick & Kyle, Associates with notifications on news.